Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Advanced Renal Technologies Inc
WARNING LETTER
•Advanced Renal Technologies Inc•April 16, 2014

Advanced Renal Technologies Inc – FDA Warning Letter, Apr 16, 2014

Record Details

During an inspection from March 24-31, 2014, and April 16, 2014, the FDA determined that Advanced Renal Technologies Inc., a specification developer of Citrasate (a dialysate for hemodialysis), manufactured adulterated devices. The manufacturing, packing, storage, or installation methods and controls did not conform to the Quality System regulation (21 CFR Part 820).

Violations included: 1. Failure to establish and maintain procedures for purchased products and services (21 CFR 820.50), with inadequate implementation and documentation of the "ART Control of Suppliers Policy." This included lack of documented communication with contract manufacturers (CMs), no documentation of FDA Establishment Inspection Report reviews for CMs, and failure to conduct required inspection visits to CMs. 2. Failure to establish and maintain quality requirements for suppliers, contractors, and consultants (21 CFR 820.50(a)), lacking a procedure defining quality requirements for CMs and documentation of contractor evaluation/selection. 3. Failure to establish and maintain corrective and preventive action (CAPA) procedures (21 CFR 820.100(a)). 4. Failure to establish and maintain design control procedures (21 CFR 820.30(a)). 5. Failure to establish quality audit procedures and conduct audits (21 CFR 8

Company
Advanced Renal Technologies Inc
Inspection date
April 16, 2014
Product type
Devices
Office
Seattle District Office
People
  • Mark Harris (E.)
  • Robin Callan
View Company Profile

ID · b2282e92-eabb-4a18-a263-518fab0ac3af

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.5021 CFR 820.100(a)21 CFR 820.30(a)21 CFR 820.2221 CFR 820.80(d)21 CFR 820.160(a)21 CFR 820.181

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Advanced Renal Technologies Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.